These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 15735046

  • 1. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.
    Shiau CW, Yang CC, Kulp SK, Chen KF, Chen CS, Huang JW, Chen CS.
    Cancer Res; 2005 Feb 15; 65(4):1561-9. PubMed ID: 15735046
    [Abstract] [Full Text] [Related]

  • 2. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
    Weng JR, Chen CY, Pinzone JJ, Ringel MD, Chen CS.
    Endocr Relat Cancer; 2006 Jun 15; 13(2):401-13. PubMed ID: 16728570
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
    Yang CC, Wang YC, Wei S, Lin LF, Chen CS, Lee CC, Lin CC, Chen CS.
    Cancer Res; 2007 Apr 01; 67(7):3229-38. PubMed ID: 17409431
    [Abstract] [Full Text] [Related]

  • 4. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
    Xiao Y, Yuan T, Yao W, Liao K.
    FEBS J; 2010 Feb 01; 277(3):687-96. PubMed ID: 20050918
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins.
    Marriott JB, Clarke IA, Czajka A, Dredge K, Childs K, Man HW, Schafer P, Govinda S, Muller GW, Stirling DI, Dalgleish AG.
    Cancer Res; 2003 Feb 01; 63(3):593-9. PubMed ID: 12566301
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG.
    J Cell Biochem; 2005 Nov 01; 96(4):760-74. PubMed ID: 16149072
    [Abstract] [Full Text] [Related]

  • 15. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
    Li M, Lee TW, Yim AP, Mok TS, Chen GG.
    J Cell Physiol; 2006 Nov 01; 209(2):428-38. PubMed ID: 16883598
    [Abstract] [Full Text] [Related]

  • 16. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
    Liu QY, Stein CA.
    Clin Cancer Res; 1997 Nov 01; 3(11):2039-46. PubMed ID: 9815595
    [Abstract] [Full Text] [Related]

  • 17. Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax.
    Xiao D, Zeng Y, Choi S, Lew KL, Nelson JB, Singh SV.
    Clin Cancer Res; 2005 Apr 01; 11(7):2670-9. PubMed ID: 15814648
    [Abstract] [Full Text] [Related]

  • 18. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS, Chen WC, Bai X, Wang YD.
    J Dig Dis; 2007 May 01; 8(2):82-8. PubMed ID: 17532820
    [Abstract] [Full Text] [Related]

  • 19. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN, Lee YR, Noh EM, Lee KS, Kim JS, Song EK, Han MK, Lee YC, Kwon KB, Lee SJ, Youn HJ, Jung SH.
    Cell Biol Int; 2008 Aug 01; 32(8):906-12. PubMed ID: 18474441
    [Abstract] [Full Text] [Related]

  • 20. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J, Qiao L, Zimmermann L, Ebert MP, Zhang H, Lin W, Röcken C, Malfertheiner P, Farrell GC.
    Hepatology; 2006 Jan 01; 43(1):134-43. PubMed ID: 16374840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.